Deep Currents Investment Group LLC Halozyme Therapeutics, Inc. Transaction History

Deep Currents Investment Group LLC

  • $46 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$16.25 - $26.81 $1.1 Million - $1.81 Million
-67,466 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$13.9 - $21.83 $2.01 Million - $3.16 Million
-144,793 Reduced 68.22%
67,466 $1.21 Million
Q4 2019

Feb 14, 2020
BUY
$14.93 - $19.53 $3.17 Million - $4.15 Million
212,259 New
212,259 $3.76 Million

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Deep Currents Investment Group LLC Portfolio

Follow Deep Currents Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Currents Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deep Currents Investment Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email